Pharmaceuticals News

Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026Two candidates nominated for...

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026Deucrictibant IR NDA under review by the FDA with PDUFA date of April 23,...

Rapid, Positive Clinical Outcomes in GBS FORWARD Study Reinforce Consistency and Reproducibility of Tanruprubart Treatment Effect Demonstrated in Phase 3 and Real-World Evidence Studies; BLA...

BRISBANE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple...

Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases

VANCOUVER, British Columbia, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...

加利福尼亚州核桃溪市 和上海, Aug. 12, 2026 (GLOBE NEWSWIRE) -- 专注于先进疗法领域的领先生命科学咨询公司 Dark Horse Consulting Group（简称 “DHCG”），今日宣布成立 Dark Horse Consulting China，并任命 Kang Liu 博士为该分公司的首位员工。新公司的办事处设于上海，体现了 DHCG...

WALNUT CREEK, California dan SHANGHAI, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (DHCG), firma perunding sains hayat terkemuka yang mengkhusus dalam terapi lanjutan, hari ini...

加州核桃溪 及上海, Aug. 12, 2026 (GLOBE NEWSWIRE) -- 專注於先進療法的頂尖生命科學顧問公司 Dark Horse Consulting Group (DHCG) 今日宣佈成立 Dark Horse Consulting China，並任命 Kang Liu 博士為首位僱員。這間設立在上海的新辦事處，體現了 DHCG...

カリフォルニア州ウォルナット・クリーク および上海発, Aug. 12, 2026 (GLOBE NEWSWIRE) -- 先進治療法を専門とする大手ライフサイエンスコンサルティング企業、ダークホース・コンサルティング・グループ (Dark Horse Consulting Group、DHCG) は本日、ダークホース・コンサルティング・チャイナ (Dark Horse Consulting...